IP Library Granted Patent US 12,544,761
Granted Patent B2
US 12,544,761 · App. 17/522,880 · Granted Feb 10, 2026

Microfluidic device and nucleic acid amplification method

Inventor: Hideki Tanabe (Osaka, JP)
Assignee: BRADY WORLDWIDE, INC.
B01L7/525B01L3/502715B01L3/502746C12Q1/6848B01L2300/042B01L2300/0663B01L2300/1805
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,544,761
App. No.
17/522,880
Granted
Feb 10, 2026
Kind
B2
Abstract

A microfluidic device for amplifying a nucleic acid includes a cartridge and a control part. The cartridge includes a tank part and a plurality of first chambers. The control part is configured to control execution of a thermal cycle, count a number of repetitions of the thermal cycle for each of the first chambers and store a count value, acquire a fluorescence intensity of each of the first chambers for each thermal cycle, and reset the count value of a defective chamber of which the fluorescence intensity is not within a predetermined range, discharge the solution from the defective chamber, and fill the defective chamber with a new solution from the tank part.

Claims (56)

1 . A microfluidic device for amplifying a nucleic acid, comprising:

a cartridge; and

a control part controlling the cartridge,

wherein the cartridge comprises

(i) a tank part storing a solution containing the nucleic acid;

(ii) a plurality of first chambers holding the solution from the tank part;

(iii) a plurality of first heaters corresponding to the plurality of first chambers; and

(iv) a plurality of flow path parts connecting the tank part and the plurality of first chambers, and

each of the plurality of first chambers comprises (a)

a first opening connected to one of the plurality of flow path parts; and

(b) a second opening for discharging the solution held in each of the plurality of first chambers, the second opening exposed on a lower surface of each of the plurality of first chambers, and

the control part is configured to:

control execution of a thermal cycle which changes a temperature of the first chambers,

count a number of repetitions of the thermal cycle for each of the first chambers and store a count value,

acquire a fluorescence intensity of each of the first chambers for each thermal cycle,

determine whether the acquired fluorescence intensity of each of the first chambers is within a predetermined range defined in advance for each number of repetitions,

determine one of the first chambers to be a defective chamber when it is determined that the fluorescence intensity is not within the predetermined range, and

reset the count value of the defective chamber, generate a bubble in the solution in the defective chamber by one of the plurality of first heaters corresponding to the defective chamber, discharge the solution from the defective chamber via the second opening by generation of the bubble, and fill the defective chamber with the solution containing the nucleic acid stored in the tank part via one of the plurality of flow path parts and the first opening.

2 . The microfluidic device according to claim 1 , wherein the cartridge comprises a plurality of first temperature sensors corresponding to the plurality of first chambers, and

the control part acquires data indicating a temperature from the plurality of first temperature sensors during the thermal cycle and manages a temperature of each of the plurality of first chambers.

3 . The microfluidic device according to claim 1 , wherein the cartridge comprises a thermal head part,

the thermal head part comprises a semiconductor substrate and a head film bonded to the semiconductor substrate,

the semiconductor substrate comprises one of the plurality of first heaters and one of the plurality of flow path parts, and

each of the first chambers and each of the flow path parts are formed as a gap formed by bonding the semiconductor substrate and the head film together.

4 . The microfluidic device according to claim 3 , wherein the semiconductor substrate comprises a substrate heater.

5 . The microfluidic device according to claim 3 , wherein the cartridge comprises a heat dissipation fin for cooling the thermal head part.

6 . The microfluidic device according to claim 5 , wherein the cartridge comprises a fan for cooling the heat dissipation fin.

7 . The microfluidic device according to claim 5 , wherein the cartridge comprises an electronic cooling element for cooling the heat dissipation fin.

8 . The microfluidic device according to claim 5 , wherein the cartridge comprises a needle-shaped heat conductive member that is inserted at an interface between the tank part and the thermal head part to conduct heat to the heat dissipation fin.

9 . The microfluidic device according to claim 1 , further comprising a cap covering the plurality of first chambers.

10 . The microfluidic device according to claim 1 , further comprising a waste liquid tray receiving the solution discharged from the defective chamber.

11 . A microfluidic device for amplifying a nucleic acid, comprising:

a cartridge; and

a control part controlling the cartridge,

wherein the cartridge comprises:

a tank part storing a solution containing the nucleic acid; and

a plurality of first chambers holding the solution from the tank part, and the control part is configured to:

control execution of a thermal cycle which changes a temperature of the first chambers,

count a number of repetitions of the thermal cycle for each of the first chambers and store a count value,

acquire a fluorescence intensity of each of the first chambers for each thermal cycle,

determine whether the acquired fluorescence intensity of each of the first chambers is within a predetermined range defined in advance for each number of repetitions,

determine one of the first chambers to be a defective chamber when it is determined that the fluorescence intensity is not within the predetermined range, and

reset the count value of the defective chamber, discharge the solution from the defective chamber, and fill the defective chamber with the solution containing the nucleic acid stored in the tank part,

the microfluidic device further comprising a plate having a plurality of wells that receive the solution discharged from the plurality of first chambers excluding the defective chamber, after completion of a predetermined number of thermal cycles.

12 . A nucleic acid amplification method in a microfluidic device, the microfluidic device comprising:

a cartridge storing a solution containing a nucleic acid; and

a control part controlling the cartridge,

wherein the cartridge comprises:

a tank part storing the solution; and

a plurality of first chambers holding the solution from the tank part, and the nucleic acid amplification method comprises:

controlling a thermal cycle which changes a temperature of the first chambers;

counting a number of repetitions of the thermal cycle for each of the first chambers and storing a count value;

acquiring a fluorescence intensity of each of the first chambers for each thermal cycle;

determining whether the acquired fluorescence intensity of each of the first chambers is within a predetermined range defined in advance for each number of repetitions;

determining the first chamber to be a defective chamber when it is determined that the fluorescence intensity is not within the predetermined range; and

resetting the count value of the defective chamber, discharging the solution from the defective chamber, and filling the defective chamber with a new solution from the tank part.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 2, 2025
From: FUNAI ELECTRIC CO., LTD.
To: BRADY WORLDWIDE, INC.
Reel/Frame 070719/0133 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 26, 2023
From: FUNAI ELECTRIC HOLDINGS CO., LTD.
To: FUNAI ELECTRIC CO., LTD.
Reel/Frame 064093/0487 →
CORRECTIVE ASSIGNMENT TO CORRECT THE NATURE OF CONVEYANCE PREVIOUSLY RECORDED AT REEL: 063815 FRAME: 0716. ASSIGNOR(S) HEREBY CONFIRMS THE CHANGE OF NAME. Recorded Jun 2, 2023
From: FUNAI ELECTRIC CO., LTD.
To: FUNAI ELECTRIC HOLDINGS CO., LTD.
Reel/Frame 063843/0907 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 31, 2023
From: FUNAI ELECTRIC CO., LTD.
To: FUNAI ELECTRIC HOLDINGS CO., LTD.
Reel/Frame 063815/0716 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 10, 2021
From: TANABE, HIDEKI
To: FUNAI ELECTRIC CO., LTD.
Reel/Frame 058067/0112 →